See also this year's filing and all EDGAR filings for this company.
PDF Report 0001072379_2024_Northwest_Biotherapeutics_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - Calc 2': 2, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)': 16}} |
Graph
Absolute values for 0001072379, Northwest Biotherapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,125,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 626,000 |
| 2 | PropertyPlantAndEquipmentNet | 17,278,000 |
| 3 | remainder_Assets | 5,836,000 |
| 4 | LiabilitiesCurrent | 45,204,000 |
| 5 | LiabilitiesNoncurrent | 29,716,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,378,086 |
| 9 | ResearchAndDevelopmentExpense | 22,527,237 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,892,436 |
| 12 | remainder_NetIncome | -6,033,879 |
| 13 | remainder_ComprehensiveNetIncome | 881,546 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 27,865,000 |
| 1 | Liabilities | 74,920,000 |
| 2 | Expenses | 52,905,323 |
| 3 | Revenues | 1,892,436 |
| 4 | StockholdersEquity | -47,055,000 |
| 5 | NetIncome | -57,046,766 |
| 6 | ComprehensiveNetIncome | -56,605,993 |
| 7 | BaseVar | 82,249,092 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.10 |
| 9 | EconomicCapitalRatio | 0.655 |
Edgar->Model Mapping
Feature Distribution
Change over Time
